AUA Summit - Planner Disclosure List

Planner Disclosure List

Name

Company

Role

Financial

Hans C. Arora, M.D.

Nothing to disclose

Jessica Bateman

American Urological Association

Employee

Yes

MR Quardricos Driskell

Nothing to disclose

James M. Dupree IV, MD

Procter and Gamble

Investment Interest

No

Blue Cross Blue Shield of Michigan

Leadership Position

Yes

Lipocine

Investment Interest

No

American Urological Association

Consultant or Advisor

Yes

Shelby Englert

Nothing to disclose

Christopher Michael Gonzalez, MD

Aurasense

Investment Interest

Yes

Coloplast

Other

No

AMS

Other

No

Brant Inman, M.D., MS, FRCSC

Dendreon

Scientific Study or Trial

No

Abbott Laboratories

Scientific Study or Trial

No

Genentech Inc

Scientific Study or Trial

No

Combat Medical

Consultant or Advisor, Scientific Study or Trial

Yes

FKD Therapies

Scientific Study or Trial

No

BioCancell

Consultant or Advisor

Yes

Nucleix

Scientific Study or Trial

Yes

Urogen

Scientific Study or Trial

Yes

Victor William Nitti MD

Astellas

Health Publishing, Scientific Study or Trial

No

Allergan

Health Publishing, Scientific Study or Trial

No

Serenity Pharmeuticals

Investment Interest

Yes

Medtronic

Scientific Study or Trial

No

Aria F. Olumi MD

Nothing to disclose

Thomas H. Rechtschaffen, MD

Astellas Pharmaceuticals US

Meeting Participant or Lecturer

Yes

Cary W. Stimson, MD

Integra Connect

Meeting Participant or Lecturer

Yes

Bradley Stine

American Urological Association

Employee

Yes

J. Stuart Wolf Jr., MD., FACS

Urology Times

Health Publishing

Yes

University of Texas Department of Surgery & Peri- operative Care

Leadership Position

Yes

Kathleen M. Zwarick PhD,CAE

Nothing to disclose